653 results on '"Bach, Peter B"'
Search Results
2. Compulsory Licensing of Pharmaceuticals in High-Income Countries : A Comparative Analysis
3. Reply to: Limitations of molecular testing in combination with computerized tomographic for lung cancer screening
4. Innovations in Early Lung Cancer Detection: Tracing the Evolution and Advancements in Screening.
5. The Prescription Drug User Fee Act: Much More Than User Fees
6. Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer
7. Trends in financial payments from industry to US cancer centers, 2014-2021.
8. The Accuracy and Usefulness of the National Comprehensive Cancer Network Evidence Blocks Affordability Rating
9. Hospital Length of Stay for Patients with Severe COVID-19: Implications for Remdesivir’s Value
10. An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries
11. Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review
12. Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population
13. Identifying and Measuring Hospital Characteristics Using the SEER-Medicare Data and Other Claims-Based Sources
14. Patient Demographic and Socioeconomic Characteristics in the SEER-Medicare Database: Applications and Limitations
15. Raising the Dose and Raising the Cost: The Case of Pembrolizumab in Lung Cancer
16. Provider Differences in Use of Implanted Ports in Older Adults With Cancer
17. Pricing in the Market for Anticancer Drugs
18. Financial Conflicts of Interest Among Oncology Clinical Pathway Vendors
19. FDA Approval of Tisagenlecleucel: Promise and Complexities of a $475 000 Cancer Drug
20. Association of Hospital Costs With Complications Following Total Gastrectomy for Gastric Adenocarcinoma
21. The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial
22. A Decade of Mortality Reductions in Major Oncologic Surgery: The Impact of Centralization and Quality Improvement
23. Geographic Access and the Use of Screening Mammography
24. Late-Stage Cancer End Points to Speed Cancer Screening Clinical Trials—Not So Fast.
25. Do Surgical Quality Gaps Cause Healthcare Disparities?
26. Potentially Avoidable Hospitalizations for COPD and Pneumonia: The Role of Physician and Practice Characteristics
27. Fragmentation of Care for Frequently Hospitalized Urban Residents
28. Racial Disparities and Site of Care
29. Overspending driven by oversized single dose vials of cancer drugs
30. Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?
31. Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer.
32. Payer and Policy Maker Steps to Support Value-Based Pricing for Drugs
33. Comorbidities, Smoking Status, and Life Expectancy Among Individuals Eligible for Lung Cancer Screening
34. Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage
35. New Math on Drug Cost-Effectiveness
36. Impact of Infection by Vancomycin‐Resistant Enterococcus on Survival and Resource Utilization for Patients With Leukemia
37. Alternative Pricing Strategies for Cancer Drugs—Reply
38. Physician Payments from Pharmaceutical Companies Related to Cancer Drugs.
39. Screening for Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
40. Association Between Quality of Care and the Sociodemographic Composition of Physicians’ Patient Panels: A Repeat Cross-Sectional Analysis
41. The debate over regional variation in health care spending
42. Indication-Specific Pricing for Cancer Drugs
43. Raising the Bar for the U.S. Preventive Services Task Force
44. Albumin-Bound Paclitaxel plus Gemcitabine in Pancreatic Cancer
45. Limits on Medicare's ability to control rising spending on cancer drugs
46. Lung Cancer Screening
47. Changes in the availability of screening mammography, 2000–2010
48. Care patterns in Medicare and their implications for pay for performance
49. Computed tomography screening and lung cancer outcomes
50. Delivery of preventive services to older adults by primary care physicians
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.